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Purpose	Acute sinusitis has viral etiology in more than 90% of cases, but antibiotics are prescribed for more
than 80% of adults in the United States. While applications of computer-assisted guidelines have been
found effective in reducing inaccurate prescribing for acute respiratory infections, there is a paucity
of research focused specifically on the utilization of electronic best practice alerts (BPA) in improving
treatment for acute sinusitis.
Methods	This observational cohort study examined prescribing behavior for sinusitis at a single Federally
Qualified Health Center 1 year prior and during the first year of implementation of a BPA in the
electronic health record (EHR) reminding providers of the recommended treatment of sinusitis. The
advisory included a link to national guidelines and a note template was installed to assist providers in
documentation. The BPA appeared on the providers’ screen when an ICD-9 code of acute or bacterial
sinusitis was entered during the patient visit.
Results 	After adjusting for select patient and provider factors, the computer-assisted guidelines effectively
reduced the overall antibiotic prescribing among these patients by 31% (relative risk: 0.69, 95%
confidence interval: 0.51–0.95) and reduced incorrect prescribing from 88.5% to 78.7% (P=0.02).
Conclusions	Clinical reminders within the EHR can be an effective tool to reduce inappropriate antibiotic use and
improve providers’ decisions regarding the correct antibiotic choices for patients with acute sinusitis.
(J Patient Cent Res Rev. 2018;5:196-203.)
Keywords	
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A

cute sinusitis, also referred to as rhinosinusitis,
is defined as inflammation of the paranasal
sinuses and nasal cavity lasting less than 4
weeks.1,2 Approximately 12% of the adult population
in the United States is diagnosed with acute sinusitis
annually, accounting for roughly 20% of all antibiotic
prescriptions per year for adults in the primary care
setting.3,4 Bacterial sinusitis, however, only occurs in
approximately 2%–10% of cases and usually results
from a secondary infection 7–10 days after the initial
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viral infection has manifested.1 Despite viral infections
causing more than 90% of cases, a 2006 review of
U.S. outpatient encounters found that antibiotics were
prescribed for 81% of adults diagnosed with acute
sinusitis.5 This data indicates that in the majority of
cases antibiotics are being used inappropriately to treat
viral sinusitis.
A recent Cochrane review examined randomized
controlled trials comparing antibiotics with placebo or
antibiotics from different classes for acute maxillary
sinusitis in adults. The authors found that 80% of
participants not treated with antibiotics improved
within 2 weeks.4 The investigators therefore argued that
clinicians must carefully balance the limited benefit
Original Research

of antibiotic against potential adverse effects. Adverse
effects of antibiotics include but are not limited to rash,
diarrhea, and Clostridium difficile infection. In addition,
inappropriate antibiotic use can increase the risk of
antibiotic resistance.6 In an effort to help guide primary
care clinicians to decrease inappropriate antibiotic
prescribing habits, the Infectious Disease Society of
America (IDSA) released clinical practice guidelines in
2012 for the diagnosis and treatment of acute bacterial
rhinosinusitis in children and adults.7
Given the high prevalence of sinusitis, coupled with
the comparative complexity of antibiotic prescribing
guidelines, several studies have examined variability in
prescribing behaviors, typically comparing health care
deliver type.8-10 These studies found variability between
primary care, urgent care, and emergency department
care on the use of antibiotics for acute sinusitis.10
In addition, variability based on provider specialty,
presence of a medical trainee, and symptom duration
each significantly influenced antibiotic prescribing.9
Previous studies in the literature report significant
reductions in inappropriate antibiotic prescriptions
using various interventions. Such interventions
included informational patient handouts, peer-to-peer
comparison, and mandatory written justification for
antibiotic prescribing within the medical record.11,12
However, most of these studies center on antibiotic
prescribing for health conditions for which antibiotics
are not recommended (ie, influenza or upper respiratory
infection). Sinusitis presents a unique challenge as the
antibiotic prescribed may be appropriate in those who
present with certain symptoms.
An older study looking at a computer-assisted
management program for antibiotics found improved
quality of care and reduced costs within that clinical
site.13 Hillestad and colleagues also identified a benefit
of electronic health records (EHR) in reducing both
adverse effects and costs.14 More recently, various
interventions involving clinical decision support
within the EHR have been studied, though the majority
of these interventions required physician training
time outside of clinic hours and resulted in modest
to insignificant reductions in antibiotic prescribing
rates.15-19 Additionally, these findings focused primarily
on acute respiratory infection protocols that were less
complicated than that for sinusitis.
Original Research

While there is little debate regarding the importance
of accurate antibiotic prescribing, complexity of
treatment for sinusitis, and efficacy of computerassisted management of medication, published research
integrating these three elements remains sparse.
Additionally, empirical examinations of the impact of
provider- and patient-level factors on how these three
elements most effectively work together are limited.
Therefore, this study seeks to understand whether
incorporation of a sinusitis-centric computer-assisted
alert on the appropriate management of antibiotics
in sinusitis can reduce overall prescribing, influence
more accurate prescribing, and balance any differential
prescribing by provider or patient characteristics.

METHODS

This was an observational cohort study conducted from
May 2013 to May 2015 in an urban federally qualified
health center and family medicine residency training
site in New York City. The clinic provides full spectrum
primary care to an ethnically and socioeconomically
diverse population, with urgent care and scheduled
primary care visits 7 days a week. Approximately
60,000 patient visits are seen annually within the clinic,
with roughly one-quarter of the patients either having no
insurance or on a government-subsidized plan. Medical
providers included 27 family medicine residents, 25
full- and part-time attending physicians of varying years
of experience, and 2 nurse practitioners of less than 5
years of experience. These medical providers work with
multidisciplinary teams made up of social workers,
psychiatrists, psychologists, a pharmacist, a certified
diabetes educator, and ancillary staff.
Intervention
All patient encounters were documented using
an EHR with the capability of including clinical
decision support tools to aid the provider, which can
be customized by the health care practice for a variety
of different medical situations. One common decision
tool utilized within the system is a best practice alert
(BPA), which is a notification that informs the provider
of evidence-based recommendations related to what
is being prescribed. One specific BPA was created
by our institution’s Pharmacy and Therapeutics
Committee related to acute sinusitis. This message
stated that acute sinusitis is caused by a virus in more
than 90% of cases. The BPA also contained a link to
the 2012 IDSA acute bacterial sinusitis guidelines7 as
www.aurora.org/jpcrr
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well as a note template to assist providers in diagnosis
of acute sinusitis at the point of care (Figure 1).

was triggered but no sinusitis diagnosis was present
in the final progress note also were excluded.

At our institution, clinicians must enter an associated
diagnosis in order to prescribe an antibiotic in the
EHR. The BPA was programmed to appear on the
provider’s computer screen at the time when the
clinician entered an ICD-9 code corresponding to
the diagnosis of acute sinusitis or bacterial sinusitis
of the patient being seen. After a 6-month process of
BPA design, testing, and editing, the final approval
was given by the clinic’s chief medical information
officer, and the BPA was activated on May 13, 2014.

Measures
We examined a dichotomous measure of antibiotic
prescribing (yes/no) to assess change in antibiotic
prescribing incidence, as correct antibiotic prescribing
is consistent with the purpose of this study. Correct
antibiotics for bacterial sinusitis was defined using
the 2012 IDSA recommendations of amoxicillin/
clavulanic acid 500 mg/125 mg orally three times daily
or 875 mg/125 mg orally twice daily. For β-lactam
allergic patients, the recommended alternatives were
doxycycline 100 mg orally twice daily or 200 mg orally
daily, levofloxacin 500 mg orally daily, or moxifloxacin
400 mg orally daily. Any of these recommended
courses of therapies were to have a duration of 5 to 7
days. In addition, we examined a dichotomous measure
of antibiotic prescribing (yes/no) to assess change in
antibiotic prescribing incidence. Provider type, patient
sociodemographic measures, and the presence of
antibiotic allergies also were evaluated.

Sample
Data was collected via a report generated in the EHR
identifying all patients who had an office visit in which
a sinusitis diagnosis was entered in the 12 months
before BPA implementation (May 14, 2013 – May 13,
2014) and 12 months after BPA implementation (May
14, 2014 – May 13, 2015). Patients were excluded if
they were under the age of 18 years, were diagnosed
with chronic sinusitis, presented for a refill of a nasal
steroid spray, or were already taking antibiotics
prescribed by another provider. Non-office visits (eg,
telephone encounters) and visits in which the BPA

Most of the data was collected via the EHR-generated
report. However, manual chart review was necessary
to correlate symptom type and length. If symptoms

Figure 1. Electronic health record sinusitis best practice alert.
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were less than that duration recommended by IDSA
for antibiotics and patient was given an antibiotic,
it was deemed to be an inappropriate antibiotic
prescription.

likelihood of any antibiotic prescribing and correct
antibiotic prescribing among patients with sinusitis
were tested using a log-binomial regression to create
relative and absolute risks.

Analyses
Statistical analyses were performed using IBM SPSS
Statistics for Windows, Version 24.0 (IBM Corp.,
Armonk, NY). Chi-squared tests were used to analyze
categorical variables. Predictive models testing the

RESULTS

During the 2-year study period, there were 438 cases
of sinusitis presented at the primary health care clinic.
More cases of sinusitis occurred in the postintervention
year (Table 1). Most patients presenting with sinusitis

Table 1. Patient and Provider Descriptives Before and After BPA Implementation
Descriptor
Age in years
Under 30
30–49
50+

Total cohort
(N=438), n (%)

Before BPA†
(n=161), %

After BPA†
(n=277), %

98 (22.4)
199 (45.4)
141 (32.2)

27.3
42.9
29.8

19.5
46.9
33.6

0.16

Race/ethnicity
White
Black
Hispanic
Other/multiple
Unknown

74 (16.9)
46 (10.5)
56 (12.8)
95 (21.7)
167 (38.1)

14.3
12.4
10.6
18
44.7

18.4
9.4
14.1
23.8
32.3

Gender
Male
Female

118 (27.0)
320 (73.0)

29.2
70.8

25.6
74.4

Allergy
None
PCN/Ceph
Other/multiple

324 (74.1)
69 (15.8)
44 (10.1)

70.8
14.3
14.9

76.1
16.7
7.2

0.12

0.42

0.04

Provider
Resident
Attending MD/DO
Nurse practitioner

110 (25.1)
203 (46.3)
125 (28.5)

24.5
34.8
40.4

25.3
53.1
21.7

Antibiotic prescribed?
No
Yes

128 (29.2)
310 (70.8)

13.7
86.3

38.3
61.7

Antibiotic prescribed correctly?*
No
Yes

P

<0.01

<0.01

0.02
256 (83.1)

88.5

78.7

52 (16.9)

11.5

21.3

*Among patients who were prescribed.
†

Before BPA = May 14, 2013 – May 13, 2014; After BPA = May 14, 2014 – May 13, 2015.

BPA, best practice alert; DO, doctor of osteopathy; MD, medical doctor; PCN/Ceph, penicillins and cephalosporins.
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during the study period were female, were 30 to 49 years
of age, and reported “unknown” race/ethnicity or none at
all. Nearly three-quarters of patients reported not having
a medication allergy. While there were no demographic
differences between patients seen during the time
period preceding the sinusitis-related prescribing BPA
compared with the year after implementation, there was
a significantly lower proportion of patients reporting
some medication allergy during the baseline period. In
addition, patients were seen by fewer nurse practitioners
and more medical doctors or doctors of osteopathy after
the BPA implementation.
Overall, prescribing of antibiotics significantly declined
after the BPA implementation from 86.3% to 61.7%
(P<0.01). When adjusting for measured covariates, the
prediction model for antibiotic prescribing after BPA
implementation showed a 31% reduction in overall
antibiotic prescribing (relative risk [RR]: 0.69, 95%
confidence interval [CI]: 0.51–0.95).
Incorrect prescribing also declined after BPA
implementation from 88.5% to 78.7% (P=0.02) for an
absolute risk reduction of 9.8%. In the prediction model

for likelihood of correct prescribing after adjusting for
measured covariates (Model 4), providers following
the BPA were more than twice as likely to prescribe
correctly after the BPA implementation (RR: 2.03, 95%
CI: 1.02–4.06). When antibiotics were prescribed, the
most frequently used IDSA criteria to justify their use
was duration of patient symptoms.
As a secondary analysis, measured covariates for
predicting overall and correct prescribing also were
examined. Models 1 and 2 (Table 2) revealed no patient
or provider factors to predict overall prescribing.
Alternatively, Model 3 identified that NPs and attending
physicians were significantly less likely to correctly
prescribe antibiotics for sinusitis compared with medical
residents before (59% and 72% less likely, respectively)
and after (53% and 75%) the BPA implementation
(Table 3). Additionally, patient race/ethnicity classified
as “Hispanic” resulted in a 3–4 times increased likelihood
of correct antibiotic prescribing compared with white
patients before and after the BPA implementation.
These data suggest that patient and provider factors
influencing correct prescribing were not eliminated by
the BPA implementation.

Table 2. Predictive Models for Overall Prescribing per Log-Binomial Regression
Antibiotic prescribing*

B

Model 1: Any prescribing
intervention excluded
SE
P
RR
95% CI

Time period (baseline control)

—

—

—

Provider NP (resident control)

0.09

(0.21)

0.68

Provider MD/DO (resident control)

0.09

(0.19)

0.62

Allergy PCN/Ceph (none control)

0.19

(0.24)

Allergy other (none control)

0.16

Gender (male control)

-0.04

Age 50+ years (under 30 control)

—

—

B

Model 2: Any prescribing
intervention included
SE
P
RR
95% CI

-0.36 (0.16) 0.02

0.69 (0.51–0.95)

1.09 (0.73–1.64)

0.02

(0.21) 0.94

1.02 (0.67–1.54)

1.10 (0.76–1.59)

0.14

(0.19) 0.47

1.15 (0.79–1.66)

0.45

1.20 (0.75–1.94)

0.11

(0.25) 0.64

1.12 (0.69–1.82)

(0.21)

0.43

1.18 (0.78–1.77)

0.18

(0.21) 0.39

1.20 (0.80–1.81)

(0.17)

0.80

0.96 (0.69–1.34) -0.04 (0.17) 0.83

0.96 (0.69–1.35)

-0.03

(0.21)

0.89

0.97 (0.65–1.46)

(0.21) 0.89

1.03 (0.68–1.54)

Age 30–49 years (under 30 control)

-0.09

(0.20)

0.66

0.92 (0.63–1.34) -0.05 (0.20) 0.80

0.95 (0.65–1.40)

Race/ethnicity unknown (white control)

0.01

(0.22)

0.97

1.01 (0.66–1.55) -0.04 (0.22) 0.87

0.97 (0.63–1.49)

Race/ethnicity black (white control)

-0.13

(0.30)

0.67

0.88 (0.49–1.59) -0.19 (0.30) 0.52

0.82 (0.46–1.49)

Race/ethnicity Hispanic (white control)

-0.09

(0.28)

0.74

0.91 (0.52–1.59) -0.09 (0.29) 0.75

0.91 (0.52–1.60)

Race/ethnicity other (white control)

-0.07

(0.24)

0.78

0.93 (0.58–1.51) -0.06 (0.25) 0.80

0.94 (0.58–1.52)

0.03

*1 = prescribed.
B, binomial estimate; CI, confidence interval; DO, doctor of osteopathy; MD, medical doctor; NP, nurse practitioner;
PCN/Ceph, penicillins or cephalosporins; RR, relative risk; SE, standard error.
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Table 3. Predictive Models for Correct Prescribing per Log-Binomial Regression
Correct antibiotic prescribing*

Model 3: Correct prescribing
intervention excluded
B
SE
P
RR
95% CI

Time period (baseline control)

—

—

—

Provider NP (resident control)

-0.88

(0.39)

0.03

Provider MD/DO (resident control)

-1.28

(0.38) <0.01 0.28 (0.13–0.59) -1.38 (0.38) <0.01 0.25 (0.12–0.54)

Allergy PCN/Ceph (none control)

0.07

(0.53)

0.89

1.08 (0.38–3.07)

0.18

(0.54)

0.74

1.20 (0.42–3.46)

Allergy other (none control)

0.42

(0.38)

0.27

1.52 (0.72–3.19)

0.33

(0.38)

0.39

1.40 (0.66–2.96)

Gender (male control)

-0.03

(0.35)

0.92

0.97 (0.48–1.93) -0.02 (0.35)

0.95

0.98 (0.49–1.96)

Age 50+ years (under 30 control)

-0.34

(0.43)

0.43

0.72 (0.31–1.66) -0.46 (0.44)

0.29

0.63 (0.27–1.48)

Age 30–49 years (under 30 control)

-0.24

(0.40)

0.54

0.78 (0.36–1.71) -0.31 (0.40)

0.44

0.73 (0.33–1.62)

Race/ethnicity unknown (white control)

1.12

(0.58)

0.05

3.07 (0.98–9.60)

1.19

(0.59)

0.04

3.29 (1.04–10.35)

Race/ethnicity black (white control)

0.13

(0.91)

0.88

1.14 (0.19–6.81)

0.30

(0.92)

0.75

1.35 (0.22–8.15)

Race/ethnicity Hispanic (white control)

1.35

(0.67)

0.04

3.84 (1.04–14.19) 1.33

(0.67)

0.05

3.76 (1.02–13.96)

Race/ethnicity other (white control)

1.04

(0.62)

0.10

2.82 (0.83–9.53)

(0.62)

0.11

2.70 (0.80–9.14)

—

—

Model 4: Correct prescribing
intervention included
B
SE
P
RR
95% CI
0.71

(0.35)

0.04

2.03 (1.02–4.06)

0.41 (0.19–0.90) -0.76 (0.40)

0.06

0.47 (0.21–1.02)

0.99

*1 = correct.
B, binomial estimate; CI, confidence interval; DO, doctor of osteopathy; MD, medical doctor; NP, nurse practitioner;
PCN/Ceph, penicillins or cephalosporins; RR, relative risk; SE, standard error.

DISCUSSION

Data collected prior to BPA implementation
demonstrated that the clinic’s rate of antibiotic
prescribing for acute sinusitis (86.3%) was similar
to national averages. This rate is a sharp contrast to
the ≤10% overall incidence of bacterial etiology of
acute sinusitis. After our intervention, the antibiotic
prescribing rates decreased to 61.7%, which is
considerably lower than national averages.
In this study, provider type played a role in accurate
prescribing; residents were more likely to prescribe
accurately compared to attending physicians and
nurse practitioners. These results are consistent with
previously published data. Roumie et al conducted
a cross-sectional study of adult patients treated
by practicing physicians, nonphysician clinicians
(physician assistants and nurse practitioners), and
residents in emergency departments, office, and
hospital practices.20 Antibiotic prescribing patterns
were compared among respiratory diagnoses for
which antibiotics are rarely indicated but for which
an antibiotic was prescribed. Nonphysician clinicians
prescribed antibiotics more often than practicing
physicians in office practices (odds ratio [OR]: 1.86,

Original Research

95% CI: 1.05–3.29) and hospital practices (OR: 1.55,
95% CI: 1.12–2.15). In hospital practices, residents
had lower prescribing rates than practicing physicians
(OR: 0.56, 95% CI: 0.36–0.86).
This study also explored overall antibiotic prescribing
for sinusitis presentations. No patient or provider
factor was found to predict that an antibiotic would be
prescribed. When adjusting for patient and provider
factors, the implementation of a prescribing BPA
reduced overall prescribing by 31%. These results
are comparable with other published reports. Linder
et al found a 5% reduction in visits with antibiotic
prescribing after implementation of a clinical decision
support for progress notes, though this was for all
acute respiratory tract infections.17 Similarly, Davis et
al reported a 24% decrease in antibiotic prescribing in
acute otitis media with the introduction of a real-time
EHR alert on evidenced-based prescribing.21 Other
reported interventions typically required an outside
intervention or training beyond the point of care.15-19
This study examined the impact of a computerassisted management tool on improving antibiotic
prescribing for patients presenting with acute sinusitis

www.aurora.org/jpcrr
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at the point of care. The implementation of a BPA
with decision-making guidance from the 2012 IDSA
sinusitis guidelines independently improved accurate
prescribing by over 100%. This supports other studies
where the impact of a computer-assisted clinical
management tool improved antibiotic prescribing.15,16
In this study, some racial disparity was noted in
our subgroup analysis wherein white patients were
more likely to have an antibiotic ordered incorrectly
compared to Hispanic status before and after the
implementation. Currently, there are very limited
published studies describing racial differences in
antibiotic prescribing for upper respiratory infections.
Two retrospective cohort studies also reported white
patients to receive more antibiotics compared to black
and Hispanic; however, these analyses only included
children.22,23 To date, our study is the only available
report that identified racial differences in antibiotic
prescribing for sinusitis in adults. Further investigation
in this area is warranted.
Limitations
One limitation of our study is that it was performed at
a single clinic site, which resulted in a smaller sample
size when compared with multicentered studies. A
larger sample may have allowed greater precision in
the models assessing overall prescribing to identify
influence of any significant provider or patient factors.
Additionally, the intervention was implemented within
a family medicine residency teaching program that
may not be generalizable to other primary care settings.
However, the diverse patient population served by
the clinic, the large number of annual visits, and the
inclusion of both residents, attending physicians, and
nurse practitioners represent a broad spectrum of both
patients and providers that may make the findings
applicable to other sites.
It also may be possible that those who actually sought
medical care may have had a more severe disease
course, making them more likely to have a bacterial
versus viral sinus infection, which may have led the
physician to prescribe the antibiotic. However, the
IDSA lists specification for the type and duration of
symptoms needed before an antibiotic is prescribed.
Those who met these criteria were classified as
being prescribed an antibiotic appropriately. Lack of
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adequate documentation of these symptoms by the
provider in the EHR may have been possible. The
BPA was built with the option to use the preset acute
sinusitis note so that adequate documentation could
be incorporated into the progress note. However, the
effectiveness of the BPA may be limited by “alert
fatigue,” causing some providers to ignore the clinical
decision support tool.24
Lastly, we are unsure why a greater number of our
patients were diagnosed with sinusitis in year 2. It
seems unlikely that this result was due to the BPA,
which fired only after the diagnosis was entered. That
said, given the increase, the improvement in correct
prescribing is even more significant.

CONCLUSIONS

Clinical decision support within the electronic health
record at the point of care can be an effective tool
to decrease inappropriate antibiotic use and improve
providers’ decisions regarding correct antibiotic
choices when treatment with antibiotics is deemed
suitable. The growing problem of antibiotic resistance
in health care makes this finding of particular
importance and necessitates further study in EHRbased interventions to reduce overprescribing of
antibiotics.

Patient-Friendly Recap
• Acute sinusitis, a common infection in adults,
is nearly always viral in nature and resolves on
its own after a few weeks.
• Despite the unlikelihood a given case is
caused by bacteria, antibiotics are very
frequently prescribed to these patients,
resulting in unwarranted exposure.
• The authors embedded an alert in the
electronic health record to educate providers
about the preferred course of treatment for
acute sinusitis.
• This “best practice alert” effectively
reduced improper prescribing of antibiotics.
Widespread application may help address the
important problem of antibiotic resistance in
the general population.

Original Research
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